X-linked agammaglobulinemia differential diagnosis
|
X-linked agammaglobulinemia Microchapters |
|
Differentiating X-linked agammaglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
X-linked agammaglobulinemia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of X-linked agammaglobulinemia differential diagnosis |
|
X-linked agammaglobulinemia differential diagnosis in the news |
|
Directions to Hospitals Treating X-linked agammaglobulinemia |
|
Risk calculators and risk factors for X-linked agammaglobulinemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differential Diagnosis
Agammaglobulinemia (XLA) is similar to the primary immunodeficiency disorder Hypogammaglobulinemia (CVID), and their clinical conditions and treatment are almost identical. However, while XLA is a congenital disorder, with known genetic causes, CVID may occur in adulthood and its causes are not yet understood.
XLA was also historically mistaken as Severe Combined Immunodeficiency (SCID), a much more severe immune deficiency ("Bubble boys").
A strain of laboratory mouse, XID, is used to study XLA. These mice have a mutated version of the mouse Btk gene, and exhibit a similar, yet milder, immune deficiency as in XLA.